18 Results

People

  1. Brentjens
    Brentjens
  2. Curran
    Curran
  3. Riviere
    Riviere
  4. Sauter
    Sauter
  5. Wang
    Wang
  6. Park
    Park
  7. Sadelain
    Sadelain
  8. Bernal
    Bernal
  9. Purdon
    Purdon
  10. Giralt
    Giralt

Groups

  1. Adult Leukemia (18)
  2. Bone Marrow Transplant (18)
  3. Center for Hematologic Malignancies (18)
  4. Department of Medicine (18)
  5. GSK Faculty (18)
  6. Hematologic Malignancies Research (18)
  7. Hematologic Malignancies, Division of (18)
  8. Pediatrics, Department of (18)
  9. Stem Cell Transplantation and Cellular Therapy Service (18)
  10. Molecular Pharmacology and Chemistry Program Faculty (15)
  1. "Hematologic Malignancies Research"
  2. "Xiuyan Wang"
  3. "Craig Sauter"
Formats
  1. Meeting Abstract (14)
  2. Journal Article (4)
Groups
  1. Adult Leukemia (18)
  2. Bone Marrow Transplant (18)
  3. Center for Hematologic Malignancies (18)
  4. Department of Medicine (18)
  5. GSK Faculty (18)
  6. Hematologic Malignancies Research (18)

More Groups

People
  1. Craig Sauter (18)
  2. Isabelle Riviere (18)
  3. Kevin Curran (18)
  4. Renier Brentjens (18)
  5. Xiuyan Wang (18)
  6. Jae Park (17)

More People

Years
  1. 2021 (1)
  2. 2020 (1)
  3. 2019 (2)
  4. 2018 (2)
  5. 2017 (3)
  6. 2016 (1)

More Years

Publications
  1. Blood (8)
  2. Journal of Clinical Oncology (2)
  3. Molecular Therapy (2)
  4. Biology of Blood and Marrow Transplantation (1)
  5. Cancer Research (1)
  6. Haematologica (1)

More Publications

Publishers
  1. American Society of Hematology (8)
  2. Nature Publishing Group (3)
  3. American Society of Clinical Oncology (2)
  4. American Association for Cancer Research (1)
  5. Elsevier Inc. (1)
  6. Ferrata Storti Foundation (1)

More Publishers

Results (18)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Depletion of high-content CD14(+) cells from apheresis products is critical for successful transduction and expansion of CAR T cells during large-scale cGMP manufacturing
    Journal Article

    Wang, X.; Borquez-Ojeda, O.; Stefanski, J.; Du, F.; Qu, J.; Chaudhari, J.; Thummar, K.; Zhu, M.; Shen, L. B.; Hall, M.; more...
    Molecular Therapy - Methods & Clinical Development (2021)

    Fulltext@MSK | Save
  • Durable remission following "off-the-shelf" chimeric antigen receptor (CAR) T-cells in patients with relapse/refractory (R/R) B-cell malignancies
    Meeting Abstract

    Curran, K. J.; Sauter, C. S.; Kernan, N. A.; Prockop, S. E.; Boulad, F.; Perales, M.; Giralt, S. A.; Riviere, I.; Wang, X.; Boelens, J. J.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL
    Journal Article

    Curran, K. J.; Margossian, S. P.; Kernan, N. A.; Silverman, L. B.; Williams, D. A.; Shukla, N.; Kobos, R.; Forlenza, C. J.; Steinherz, P.; Prockop, S.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • CD19 CAR T cells following autologous transplantation in poor-risk relapsed and refractory B-cell non-Hodgkin lymphoma
    Journal Article

    Sauter, C. S.; Senechal, B.; Rivière, I.; Ni, A.; Bernal, Y.; Wang, X.; Purdon, T.; Hall, M.; Singh, A. N.; Szenes, V. Z.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Clinical responses and pharmacokinetics of MCARH171, a human-derived BCMA targeted CAR T cell therapy in relapsed/refractory multiple myeloma: Final results of a phase I clinical trial
    Meeting Abstract

    Mailankody, S.; Ghosh, A.; Staehr, M.; Purdon, T. J.; Roshal, M.; Halton, E.; Diamonte, C.; Pineda, J.; Anant, P.; Bernal, Y.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Long-term follow-up of CD19 CAR therapy in acute lymphoblastic leukemia
    Journal Article

    Park, J. H.; Rivière, I.; Gonen, M.; Wang, X.; Sénéchal, B.; Curran, K. J.; Sauter, C.; Wang, Y.; Santomasso, B.; Mead, E.; more...
    New England Journal of Medicine (2018)

    Fulltext@MSK | Save
  • Development and evaluation of a human single chain variable fragment (scFv) derived BCMA targeted CAR T Cell vector leads to a high objective response rate in patients with advanced MM
    Meeting Abstract

    Smith, E. L.; Mailankody, S.; Ghosh, A.; Masakayan, R.; Staehr, M.; Purdon, T. J.; Halton, E.; Diamonte, C.; Anant, P.; Bernal, Y.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • A Phase I trial of 19-28z CAR-T cells post-high dose therapy and autologous transplantation (HDT-ASCT) for relapsed and refractory (R/R) B-cell non-Hodgkin lymphoma (B-NHL)
    Meeting Abstract

    Sauter, C.; Riviere, I.; Senechal, B.; Ni, A.; Bernal, Y.; Wang, X.; Purdon, T.; Hall, M.; Moskowitz, C.; Giralt, S.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save
  • Disease burden and transplant on long-term survival after CD19 CAR T cells in adults with relapsed acute lymphoblastic leukemia
    Meeting Abstract

    Park, J.; Rivere, I.; Wang, X. Y.; Senechal, B.; Curran, K.; Sauter, C.; Wang, Y. Z.; Li, D.; Brentjens, R.; Sadelain, M.
    Molecular Therapy (2017)

    Fulltext@MSK | Save
  • Chimeric antigen receptor T cells for cancer immunotherapy
    Meeting Abstract

    Curran, K. J.; Silverman, L. B.; Kobos, R.; Kernan, N. A.; Margossian, S. P.; Park, J. H.; Sauter, C. S.; Szenes, V.; Wang, X. Y.; O'Reilly, R. J.; more...
    Cancer Research (2016)

    Fulltext@MSK | Save